# FDA Inspection 1150528 - Geisinger Institutional Review Board - August 06, 2021

Source: https://www.keypedia.com/records/fda_inspections/geisinger-institutional-review-board/21ee2e4e-3f34-47f0-9aee-7727aa80df95
Source feed: FDA_Inspections

> FDA Inspection 1150528 for Geisinger Institutional Review Board on August 06, 2021. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1150528
- Company Name: Geisinger Institutional Review Board
- Inspection Date: 2021-08-06
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs

## Related Documents

- [FDA Inspection 1150528 - 2021-08-06](https://www.keypedia.com/records/fda_inspections/geisinger-institutional-review-board/2b81d93b-0828-4a97-84a5-46edc810421a)
- [FDA Inspection 1150528 - 2021-08-06](https://www.keypedia.com/records/fda_inspections/geisinger-institutional-review-board/2acc2955-9139-4744-9ef5-2799f4b8993c)
- [FDA Inspection 917243 - 2015-03-06](https://www.keypedia.com/records/fda_inspections/geisinger-institutional-review-board/29dbe803-9c9b-4004-bdf4-ee61f2656250)
- [FDA Inspection 604266 - 2009-08-06](https://www.keypedia.com/records/fda_inspections/geisinger-institutional-review-board/a7078eeb-fd34-455c-be80-a5f9580b9e4c)

Company: https://www.keypedia.com/companies/geisinger-institutional-review-board/642568fc-45be-4e8b-a897-ab0183f483e0